Larvol Delta - A-Study-of-OVV01-Injection-in-Combination-With-IBR900-Cell-Injection-in-Patients-With-Advanced-Malignant-Tumors

IBR900 - Imbioray Bio

OVV-01 - Joint Biosci, Beijing Boren Hospital

http://clinicaltrials.gov/ct2/show/NCT05271279

Nov 2, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next